Additionally, patients with SSc who are double positive for ATA and anti-PRMT5 antibodies also exhibited a numerical predominance for the diffuse cutaneous subset (11/15, 73.33%) compared with the limited cutaneous subset (4/15, 26.67%) but without statistical significance (figure 5D). The gene discussed is PRMT5; the disease is systemic sclerosis.